These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 25539748)
1. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. He Z; Lu C; Chren MM; Zhang Z; Li Y; Ni X; Buchtel V HA; Ryan PF; Li GZ Health Qual Life Outcomes; 2014 Dec; 12():190. PubMed ID: 25539748 [TBL] [Abstract][Full Text] [Related]
2. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity. AlGhamdi KM; AlShammari SA Int J Dermatol; 2007 Mar; 46(3):247-52. PubMed ID: 17343578 [TBL] [Abstract][Full Text] [Related]
3. Translation and Validation of the Serbian Version of the Skindex-29 Instrument for Measuring Impact of Skin Disease on Quality of Life. Milutinović JD; Krstić N; Janković SM Acta Dermatovenerol Croat; 2017 Jul; 25(2):120-127. PubMed ID: 28871926 [TBL] [Abstract][Full Text] [Related]
4. The Spanish version of Skindex-29. Jones-Caballero M; Peñas PF; García-Díez A; Badía X; Chren MM Int J Dermatol; 2000 Dec; 39(12):907-12. PubMed ID: 11168659 [TBL] [Abstract][Full Text] [Related]
5. Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease. Essa N; Awad S; Nashaat M Int J Behav Med; 2018 Apr; 25(2):243-251. PubMed ID: 28748378 [TBL] [Abstract][Full Text] [Related]
6. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. Higaki Y; Kawamoto K; Kamo T; Horikawa N; Kawashima M; Chren MM J Dermatol; 2002 Nov; 29(11):693-8. PubMed ID: 12484430 [TBL] [Abstract][Full Text] [Related]
7. Turkish version of Skindex-29. Aksu AE; Urer MS; Sabuncu I; Saracoglu ZN; Chren MM Int J Dermatol; 2007 Apr; 46(4):350-5. PubMed ID: 17442071 [TBL] [Abstract][Full Text] [Related]
8. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases. Cárcano CBM; de Oliveira CZ; Paiva BSR; Paiva CE PLoS One; 2018; 13(3):e0194492. PubMed ID: 29566036 [TBL] [Abstract][Full Text] [Related]
9. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco. El Fakir S; Baybay H; Bendahhou K; Obtel M; Benchat L; Mernissi FZ; Nejjari C J Dermatolog Treat; 2014 Apr; 25(2):106-9. PubMed ID: 22455447 [TBL] [Abstract][Full Text] [Related]
10. Cross validation of the Turkish version of dermatology life quality index. Oztürkcan S; Ermertcan AT; Eser E; Sahin MT Int J Dermatol; 2006 Nov; 45(11):1300-7. PubMed ID: 17076710 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Skindex-29 Questionnaire: Portuguese Version (Portugal). Carvalho D; Aguiar P; Palma-Carlos A Acta Med Port; 2018 Sep; 31(9):463-469. PubMed ID: 30332369 [TBL] [Abstract][Full Text] [Related]
12. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. He Z; Lu C; Basra MK; Ou A; Yan Y; Li L J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712 [TBL] [Abstract][Full Text] [Related]
13. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. Chren MM; Lasek RJ; Sahay AP; Sands LP J Cutan Med Surg; 2001; 5(2):105-10. PubMed ID: 11443481 [TBL] [Abstract][Full Text] [Related]
14. Japanese version of the Family Dermatology Life Quality Index: Translation and validation. Higaki Y; Tanaka M; Futei Y; Kamo T; Basra MKA; Finlay AY J Dermatol; 2017 Aug; 44(8):914-919. PubMed ID: 28342225 [TBL] [Abstract][Full Text] [Related]
15. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Abeni D; Picardi A; Pasquini P; Melchi CF; Chren MM Dermatology; 2002; 204(1):43-9. PubMed ID: 11834849 [TBL] [Abstract][Full Text] [Related]
16. Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients. Meneguin S; de Souza Matos TD; Pollo CF; Garuzi M; Miot HA; de Oliveira C PLoS One; 2021; 16(8):e0254882. PubMed ID: 34388159 [TBL] [Abstract][Full Text] [Related]
17. Translation and psychometric validation of a Danish version of the medication-related quality of life scale. Lech LVJ; Jónsdóttir ED; Niclasen J; Treldal C; Graabæk T; Almarsdóttir AB Int J Clin Pharm; 2020 Apr; 42(2):667-676. PubMed ID: 32026349 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of the Chinese version of dry eye related quality of life scale. Zheng B; Liu XJ; Sun YF; Su JZ; Zhao Y; Xie Z; Yu GY Health Qual Life Outcomes; 2017 Jul; 15(1):145. PubMed ID: 28716084 [TBL] [Abstract][Full Text] [Related]
19. Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine. Chang HY; Jensen MP; Yang CC; Lai YH Health Qual Life Outcomes; 2019 Jun; 17(1):108. PubMed ID: 31234894 [TBL] [Abstract][Full Text] [Related]
20. The reliability and validity of Chinese version of SF36 v2 in aging patients with chronic heart failure. Dong A; Chen S; Zhu L; Shi L; Cai Y; Zeng J; Guo W Aging Clin Exp Res; 2017 Aug; 29(4):685-693. PubMed ID: 27518815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]